Provided by Tiger Trade Technology Pte. Ltd.

CALCIMEDICA

0.5728
-0.0104-1.78%
Post-market: 0.58140.0086+1.50%18:48 EDT
Volume:271.59K
Turnover:157.06K
Market Cap:19.56M
PE:-0.43
High:0.6000
Open:0.5930
Low:0.5608
Close:0.5832
52wk High:7.20
52wk Low:0.4606
Shares:34.14M
Float Shares:19.81M
Volume Ratio:0.75
T/O Rate:1.37%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3306
EPS(LYR):-1.9700
ROE:-365.70%
ROA:-63.58%
PB:3.55
PE(LYR):-0.29

Loading ...

Company Profile

Company Name:
CALCIMEDICA
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
16
Office Location:
505 Coast Boulevard South,Suite 307,La Jolla,California,United States
Zip Code:
92037
Fax:
- -
Introduction:
CalciMedica, Inc. was incorporated in February 2015 under the laws of Delaware. The company is a clinical-stage biopharmaceutical company focused on developing therapies for serious diseases driven by inflammatory and immune processes as well as direct cellular damage. Its product candidates target calcium release-activated calcium ("CRAC") channels and would constitute a new class of drugs.

Directors

Name
Position
A. Rachel Leheny
Chief Executive Officer and Director
Eric W. Roberts
Chief Business Officer, Director and Vice Chairman of the Board
Robert N. Wilson
Chairman of the Board
Alan Glicklich
Independent Director
Allan Shaw
Independent Director
Evgeny Zaytsev
Independent Director
Frederic Guerard
Independent Director

Shareholders

Name
Position
A. Rachel Leheny
Chief Executive Officer and Director
Michael J. Dunn
Chief Operating Officer and President
Stephen Bardin
Chief Financial Officer
Eric W. Roberts
Chief Business Officer, Director and Vice Chairman of the Board
Kenneth A. Stauderman
Chief Scientific Officer
Sudarshan Hebbar
Chief Medical Officer